Annexon (ANNX) Exchange Rate Effect (2019 - 2026)

Annexon (ANNX) posted quarterly Exchange Rate Effect of $1000.0 for Q1 2026, down 50.0% quarter-over-quarter from $2000.0 in Q2 2025.

Annexon (ANNX) Exchange Rate Effect (2019 - 2026) Analysis & Trends

Annexon's Exchange Rate Effect history runs 8 years deep, the most recent figure standing at $1000.0 for Q1 2026.

In Q1 2026, Exchange Rate Effect changed N/A year-over-year to $1000.0; the TTM figure through Mar 2026 stood at $3000.0 (up 200.0% YoY), while the FY2025 annual figure was $2000.0, up 113.33% from the prior year.
Exchange Rate Effect for Q1 2026 stood at $1000.0, down from $2000.0 in the prior quarter.
The five-year high for Exchange Rate Effect was $13000.0 in Q4 2023, with the low at -$12000.0 in Q1 2024.
The 5-year median for Exchange Rate Effect is $0.0 (2023), against an average of -$428.57.
Peak annual rise in Exchange Rate Effect reached 400.0% in 2022, while the deepest fall reached 500.0% in 2022.
Annexon's Exchange Rate Effect stood at $8000.0 in 2022, then jumped by 62.5% to $13000.0 in 2023, then plunged by 146.15% to -$6000.0 in 2024, then soared by 133.33% to $2000.0 in 2025, then slumped by 50.0% to $1000.0 in 2026.
Business Quant data shows ANNX's Exchange Rate Effect at $1000.0 in Q1 2026, $2000.0 in Q2 2025, and -$6000.0 in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Exchange Rate Effect (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-3.70 Mn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	-300,000.00
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	19.84 Mn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-14,590.12
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-2.45 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-287,000.00
10	Annexon	1.00 Bn	1.00 Bn	-	-

Download Data